Related Experiment Video
Updated: Mar 29, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
Published on: May 19, 2016
PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion
Anna E Dart1, Gary M Box2, William Court2
1Division of Cancer Studies, King's College London, London SE1 1UL, England, UK.
Abstract:
P21-activated kinase 4 (PAK4) is a Cdc42 effector protein thought to regulate cell adhesion disassembly in a kinase-dependent manner. We found that PAK4 expression is significantly higher in high-grade human breast cancer patient samples, whereas depletion of PAK4 modifies cell adhesion dynamics of breast cancer cells. Surprisingly, systematic analysis of PAK4 functionality revealed that PAK4-driven adhesion turnover is neither dependent on Cdc42 binding nor kinase activity. Rather, reduced expression of PAK4 leads to a concomitant loss of RhoU expression. We report that RhoU is targeted for ubiquitination by the Rab40A-Cullin 5 complex and demonstrate that PAK4 protects RhoU from ubiquitination in a kinase-independent manner. Overexpression of RhoU rescues the PAK4 depletion phenotype, whereas loss of RhoU expression reduces cell adhesion turnover and migration. These data support a new kinase-independent mechanism for PAK4 function, where an important role of PAK4 in cellular adhesions is to stabilize RhoU protein levels. Thus, PAK4 and RhoU cooperate to drive adhesion turnover and promote cell migration.
Insights
P21-activated kinase 4 (PAK4) stabilizes RhoU protein levels, promoting breast cancer cell migration. This kinase-independent function is crucial for cell adhesion dynamics and cancer progression.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- P21-activated kinase 4 (PAK4) is implicated in cell adhesion dynamics, often linked to its kinase activity and Cdc42 binding.
- Elevated PAK4 expression is observed in high-grade human breast cancers, suggesting a role in tumorigenesis.
Purpose of the Study:
- To elucidate the precise mechanism of PAK4's function in regulating cell adhesion and migration.
- To investigate the relationship between PAK4, Cdc42, kinase activity, and RhoU in breast cancer cells.
Main Methods:
- Analysis of PAK4 expression in human breast cancer samples.
- Depletion of PAK4 in breast cancer cells to observe effects on cell adhesion dynamics.
- Systematic functional analysis of PAK4, including Cdc42 binding and kinase activity assays.
- Investigation of RhoU expression and its regulation by PAK4.
- Ubiquitination assays involving the Rab40A-Cullin 5 complex and RhoU.
- Rescue experiments with RhoU overexpression and RhoU loss-of-function studies.
Main Results:
- PAK4 expression is significantly higher in high-grade breast cancer.
- PAK4-mediated adhesion turnover is independent of Cdc42 binding and kinase activity.
- PAK4 depletion leads to reduced RhoU expression.
- PAK4 protects RhoU from ubiquitination by the Rab40A-Cullin 5 complex in a kinase-independent manner.
- RhoU overexpression rescues the PAK4 depletion phenotype, while RhoU loss reduces cell adhesion turnover and migration.
Conclusions:
- PAK4 regulates cell adhesion and migration through a novel kinase-independent mechanism involving RhoU stabilization.
- PAK4 protects RhoU from ubiquitination and degradation, thereby maintaining its protein levels.
- PAK4 and RhoU function cooperatively to drive adhesion turnover and promote breast cancer cell migration.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cell Polarization by Rho Proteins
PI3K/mTOR/AKT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
MAPK Signaling Cascades
Receptor Tyrosine Kinases

